Scinai Regains Nasdaq Compliance After 19-Day Bid Price Hold

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) has regained compliance with Nasdaq’s minimum bid price rule of $1.00 per American Depositary Share (ADS), following a period of non-compliance that prompted a formal notification in March. The company’s ADSs maintained a closing bid price at or above $1.00 for 19 consecutive business days between August 21 and September 17, according to Nasdaq’s review. Nasdaq confirmed this compliance on September 18, marking the resolution of an earlier violation detected on March 12, when the company’s ADSs failed to meet the $1.00 minimum bid price over 30 consecutive days.